#impaktWISE
Submit your project to the #impaktWISE Awards
To submit your idea to the #impaktWISE Awards, you first need to create your project on Babele. This will be the basis for the jury evaluation. We are open to teams of all sizes (including solo participants) but recommend participating in teams of 2-4 people.
Please note that the submission for this round of the competition is now closed. Join our virtual event on February 10th, 2022 to find out who the winners are.
Choose between two categories
Ideation Awards
Focused on innovative, early-stage ideas
You must fill out element 1-5 of your business model
Winners receive a certificate and further support from #impaktWISE team
Pitch Awards
Focused on ideas ready to be taken to the next level
You must fill out element 1-10 of your business model
Winners receive 20,000 DKK sponsored by Abacus Medicine, and further support from #impaktWISE team
Evaluation criteria
Our expert jury will evaluate your project and decide on the winners of each category based on the following criteria
Novelty of the idea
How innovative is the proposed solution?
Quality of problem identification and solution
Is the identified problem and solution clear and convincing?
Impact potential
How much impact does the idea have on its beneficiaries?
Relevance of the social problem
How relevant is the problem in today's society?
Applicability and scalability
Can the idea be easily implemented and scaled?
Applies only to the Pitch Awards
Meet the Jury
Maxie Matthiessen
Maxie Matthiessen is a serial entrepreneur with a passion for women's health and social impact. She has founded two companies, Ruby Cup and FEMNA Health. Ruby Cup (founded at CBS) is a pioneer period company with a designated social mission to give all girls and women access to sustainable female hygiene. FEMNA Health is the first and leading tele-medicine platform in Germany focusing on women's health.
Daniel Halalla
Daniel is a social entrepreneur focusing on creating long-term social, environmental and economic impact with coffee farmers. Coffee is the second most traded commodity after oil, but the farmers get little for their product. Therefore, Daniel started Impact Roasters four years ago to empower coffee farmers economically while preserving the natural environment. Currently, Impact Roasters has 3 roasters in Copenhagen which work directly with coffee farmers in Ethiopia. Their trade model is called Impact Trade.
.jpg)
Gregor Halff
Gregor Halff has been Dean of Education and Professor (with special responsibilities) at Copenhagen Business School since 2018 and was earlier Professor and Deputy Dean at Singapore Management University. Since 2005, Gregor has developed, grown and run ranked programmes at the undergraduate, graduate, MBA, executive and doctoral levels, as well as for armies, navies, and major international corporations. He has served as Chair of the Global Alliance for Public Relations and Communication Management, the world's global umbrella association for the public relations sector, representing over 200 000 practitioners. Prior to joining academia, Gregor was managing partner at Publicis Groupe, one of the world's major communication agencies, where he co-founded Publicis Public Relations (today MSL Group). Originally from The Netherlands, Gregor has also taught in Taipei, Hyderabad, Auckland, Dubai, Tashkent, Stockholm, Nairobi, LA, and Lugano.
Mogens Hobolth
Mogens Hobolth is the Executive Vice President of Abacus Medicine, and holds a PhD from the London School of Economics and Political Science. As the head of Enterprise Systems & Analytics, Mr. Mogens Hobolth sits at the very heart of the data-heavy business model of Abacus Medicine. From data lake infrastructure to machine learning, Mogens leads a medium-sized army of developers, data analysts and project managers which help all parts of the global organization to grow their business. Today, Abacus Medicine has grown to more than 1,000 employees, but an entrepreneurial spirit remains a key element in the company’s culture. Abacus Medicine is now one of the market leaders within parallel distribution in Europe and continues to work for better healthcare through better access to medicine.